Hellenic Cooperative Oncology Group

Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)

Collaborator, Phase 3, Recruiting, 2023, 220 people, 23 Aug 2022, clinicaltrials.gov

NCT02882308

Phase 2, Completed, 2016, 41 people, 29 Aug 2016, clinicaltrials.gov

NCT01648465

Phase 2, Terminated, 2012, 25 people, 24 Jul 2012, clinicaltrials.gov

NCT00981708

Collaborator, Phase 1/2, Completed, 2008, 37 people, 22 Sept 2009, clinicaltrials.gov